---
title: "Vaccinex to delist its common stock (OTC: VCNX) from Nasdaq due to trading suspension since Dec 18, 2024."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231442178.md"
description: "On March 7, 2025, Vaccinex, Inc. (OTC: VCNX) revealed its intention to delist its common stock from the Nasdaq Stock Market. The clinical-stage biotech company halted trading of its stock on Nasdaq since December 18, 2024, due to its innovative approach in treating neurodegenerative diseases. By inhibiting SEMA4D, Vaccinex aims to combat astrogliosis and neuroinflammation. The company's decision to delist follows the notification provided to Nasdaq."
datetime: "2025-03-11T23:37:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231442178.md)
  - [en](https://longbridge.com/en/news/231442178.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231442178.md)
generator: "portal-rs"
---

# Vaccinex to delist its common stock (OTC: VCNX) from Nasdaq due to trading suspension since Dec 18, 2024.

On March 7, 2025, Vaccinex, Inc. (OTC: VCNX) revealed its intention to delist its common stock from the Nasdaq Stock Market. The clinical-stage biotech company halted trading of its stock on Nasdaq since December 18, 2024, due to its innovative approach in treating neurodegenerative diseases. By inhibiting SEMA4D, Vaccinex aims to combat astrogliosis and neuroinflammation. The company's decision to delist follows the notification provided to Nasdaq.

### Related Stocks

- [VCNX.US](https://longbridge.com/en/quote/VCNX.US.md)

## Related News & Research

- [Live Nation Entertainment (LYV) Expands Venues As Investors Weigh Its Valuation](https://longbridge.com/en/news/305560320.md)
- [How Shelf Registration Will Impact Celldex Therapeutics (CLDX) Stock Investors](https://longbridge.com/en/news/305560069.md)
- [Tango Therapeutics (TNGX) Climbed, So What Is Driving Attention Now?](https://longbridge.com/en/news/305573939.md)
- [GE HealthCare Technologies (GEHC) Tests Its Brain Imaging Narrative As Undervalued View Holds](https://longbridge.com/en/news/305561290.md)
- [Missed Viasat's 88% Gain? Here's What Investors Got Right](https://longbridge.com/en/news/305561187.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**